Olivia C Ware insider trades

Open-market stock purchases and sales by Olivia C Ware, Director at Contineum Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2016.

Recent trades

DateStockTradeValue
Jun 26, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Apr 28, 2026ACLX Arcellx, IncSold (not open market)$280K
Apr 28, 2026ACLX Arcellx, IncSold (not open market)$435K
Apr 28, 2026ACLX Arcellx, IncSold (not open market)$411K
Apr 28, 2026ACLX Arcellx, IncSold (not open market)$584K

Companies traded

  • CTNM Contineum Therapeutics, Inc: other filings, last Jun 26, 2026
  • ACLX Arcellx, Inc: 5 sales, last Apr 28, 2026
  • RVNC Revance Therapeutics, Inc: other filings, last Feb 6, 2025
  • CYTR Cytrx Corp: other filings, last Jan 11, 2016

Get free alerts when Olivia C Ware files a new trade →